Nilesh Goswami, MD
Interventional Cardiology · Waco, TXNPI 1467534701
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Medtronic at 41.7% of the total.
Across 532 payments — averaging $117.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$26K
- Boston Scientific$19K
- Edwards Lifesciences$3K
- Abbott$2K
- Penumbra, Inc.$2K
- Inari Medical, Inc.$2K
- plus $7K from 31 others
Across 178 payments — averaging $2685.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$258K
- Abbott$101K
- Angiodynamics, Inc.$42K
- Shockwave Medical, Inc$35K
- Medtronic$14K
- Livanova USA, Inc.$13K
- plus $15K from 2 others
What the payments were for
- Consulting fees$7,57512%
- Speaking & faculty fees$27,70644%
- Grants$890%
- Travel & lodging$7,40612%
- Food & beverage$19,46231%
- Education$810%
- Gifts$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 128 | $26,016 |
| Boston Scientific | 54 | $18,998 |
| Edwards Lifesciences | 25 | $3,311 |
| Abbott | 73 | $2,432 |
| Penumbra, Inc. | 11 | $2,307 |
| Inari Medical, Inc. | 41 | $1,813 |
| Stryker | 12 | $1,344 |
| W. L. Gore & Associates, Inc. | 15 | $807 |
| Shockwave Medical, Inc | 7 | $705 |
| Abiomed | 12 | $614 |
| Endologix LLC | 6 | $600 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $331 |
| E.r. Squibb & Sons, L.L.C. | 16 | $280 |
| Amgen | 13 | $269 |
| Livanova USA, Inc. | 3 | $262 |
| Philips North America LLC | 3 | $243 |
| Johnson & Johnson(2 entities) | 18 | $238 |
| Novartis | 12 | $238 |
| AstraZeneca | 12 | $214 |
| Pfizer | 9 | $188 |
| Biotronik Inc. | 10 | $186 |
| Boehringer Ingelheim | 6 | $131 |
| Novo Nordisk | 2 | $120 |
| Regeneron Healthcare Solutions, Inc. | 6 | $114 |
| Merck | 1 | $110 |
| Getinge USA Sales, LLC | 3 | $91 |
| Angiodynamics, Inc. | 1 | $66 |
| Teleflex LLC | 3 | $57 |
| Cardiovascular Systems Inc. | 2 | $57 |
| Welch Allyn | 1 | $42 |
| Amarin Pharma, Inc. | 3 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $40 |
| BD | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Neuros Medical, Inc. | 1 | $18 |
| Cardinal Health 200 LLC | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$9,212
- CoreValve Evolut$7,668
- GENERAL - STRUCTURAL HEART$7,028
- GENERAL - THERAPIES$5,962
- Mo.Ma$5,813
- Watchman$4,400
- Indigo System$2,121
- PASCAL$2,003
- FLOWTRIEVER CATHETER, S$1,902
- CT THROMBECTOMY SYSTEM KIT$1,902
- AMPLATZER Occluders$541
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$516
- Alto Abdominal Stent Graft System$474
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$450
- FlowTriever$271
- VERQUVO$219
- AMS$207
- LOTUS EDGE$192
- ANGIOJET$182
- GORE VIABAHN VBX Balloon Expandable Endo$149
How this compares
$62,361 in reported general payments places this provider in the 85th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 147 | $114,230 |
| EntrestoSacubitril/Valsartan | 34 | $29,840 |
| Repatha SureclickEvolocumab | 27 | $19,423 |
| FarxigaDapagliflozin Propanediol | 18 | $15,002 |
| JardianceEmpagliflozin | 16 | $13,613 |
| BrilintaTicagrelor | 12 | $9,487 |
| Metoprolol Succinate | 399 | $5,693 |
| ClopidogrelClopidogrel Bisulfate | 196 | $2,226 |
| Ezetimibe | 71 | $2,220 |
| Rosuvastatin Calcium | 104 | $2,185 |
| Atorvastatin Calcium | 149 | $1,616 |
| Lisinopril | 107 | $1,192 |
| Spironolactone | 103 | $815 |
| Carvedilol | 73 | $750 |
| Valsartan | 23 | $597 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $188 | $114,230147 claims |
| NovartisEntresto | $238 | $29,84034 claims |
| AstraZenecaFarxiga, Brilinta | $214 | $24,48930 claims |
| Boehringer IngelheimJardiance | $131 | $13,61316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 686 interventional cardiology providers in Texas.
Other interventional cardiology in Waco
- Juan GranadaHouston$4.1M
- Vamsi KrishnaKyle$2M
- Jeffrey CarrTyler$1.9M
- John IsaacHouston$1.8M
- Robert ChiltonSan Antonio$1.3M
- Sameh SayfoPlano$1M
- Srinivasa PotluriPlano$781K
- Karim Al-AziziPlano$734K
- Robert StolerDallas$587K
- Peter MonteleoneKyle$461K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.